EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer

Joanna Słoka, Marcel Madej, Barbara Strzalka-Mrozik iD

Molecules · 2023

DOI: 10.3390/molecules28135081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Joanna Słoka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Colorectal Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Górnośląsko - Zagłębiowska Metropolis, the Górnośląsko-Zagłębiowską Metropolis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoprevention is one of the ways to fight colorectal cancer, which is a huge challenge in oncology. Numerous pieces of evidence indicate that chronic inflammation in the course of Crohn’s disease or ulcerative colitis (UC) is a significant cancer risk factor. Epidemiologic studies suggest that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), including mesalazine, has beneficial effects on colitis-associated colorectal cancer. Mesalazine is a first-line therapy for UC and is also widely used for maintaining remission in UC. Data showed that mesalazine has antiproliferative properties associated with cyclooxygenase (COX) inhibition but can also act through COX-independent pathways. This review summarizes knowledge about mesalazine’s molecular mechanisms of action and chemopreventive effect by which it could interfere with colorectal cancer cell proliferation and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseColorectal NeoplasmsHumansMesalamineAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

Wnt/β-catenin pathwaycancer stem cellschemopreventioncolorectal cancerinflammationmesalazinemolecular mechanismnon-steroidal anti-inflammatory drugs

Substanzen

MesalamineAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland.

ORCID-Profile: Barbara Strzalka-Mrozik

Förderung

  • The Górnośląsko - Zagłębiowska Metropolis
  • the Górnośląsko-Zagłębiowską Metropolis

Zitieren

APA

Słoka, J., Madej, M., & Strzalka-Mrozik, B. (2023). Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer. Molecules. https://doi.org/10.3390/molecules28135081

Vancouver

Słoka J, Madej M, Strzalka-Mrozik B. Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer. Molecules. 2023. doi:10.3390/molecules28135081

BibTeX
@article{Soka2023,
  author = {Słoka, Joanna and Madej, Marcel and Strzalka-Mrozik, Barbara},
  title = {Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28135081}
}
Kostenlos starten →